CHA News

CDPH Issues Update Information on COVID-19 Resources for SNFs

This post has been archived and contains information that may be out of date.

The California Department of Public Health (CDPH) has issued All Facilities Letter (AFL) 23-29, recommending that all residents of skilled-nursing facilities (SNFs) with symptomatic COVID-19 be evaluated by a prescribing clinician to be considered for COVID-19 therapeutics, any oral COVID-19 therapeutics drug-drug interaction risk, and/or renal and hepatic impairment in advance of a COVID-19 diagnosis.  

Additionally, CDPH notes that SNFs should record such information in health records in order to facilitate resident access to appropriate therapeutics when a COVID-19 diagnosis is made. This AFL also provides information regarding available guidance and resources for evaluating, prescribing, and obtaining COVID-19 therapeutics for SNF residents and recommends SNFs provide information on appropriate therapeutics to their health care personnel who have symptomatic COVID-19. This AFL revision includes the latest authorized COVID-19 treatments with the recommended timing for effectiveness.